Inventor
GOLDMAKHER VIKTOR S
US20 patents
⚠️ This page may combine multiple inventors who share the name “GOLDMAKHER VIKTOR S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNOGEN INC
12 patentsUS5846545ADec 8, 1998
Targeted delivery of cyclopropylbenzindole-containing cytotoxic drugs
IMMUNOGEN INC531 citations99
US5585499ADec 17, 1996
Cyclopropylbenzindole-containing cytotoxic drugs
IMMUNOGEN INC541 citations99
US5475092ADec 12, 1995
Cell binding agent conjugates of analogues and derivatives of CC-1065
IMMUNOGEN INC668 citations99
US9670279B2Jun 6, 2017
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC26 citations98
US9133275B2Sep 15, 2015
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC45 citations98
US10752683B2Aug 25, 2020
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC13 citations94
US10301385B2May 28, 2019
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC8 citations92
US9670280B2Jun 6, 2017
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC19 citations92
US9670278B2Jun 6, 2017
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC18 citations92
US9657100B2May 23, 2017
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC16 citations92
US9598490B2Mar 21, 2017
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC18 citations92
US7449450B2Nov 11, 2008
Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
IMMUNOGEN INC1 citations60
GOLDMAKHER VIKTOR S
3 patentsUS8388960B2Mar 5, 2013
Elimination of heterogeneous or mixed cell population in tumors
GOLDMAKHER VIKTOR S7 citations81
US8137669B2Mar 20, 2012
Elimination of heterogeneous or mixed cell population in tumors
GOLDMAKHER VIKTOR S7 citations81
US8840898B2Sep 23, 2014
Immunoconjugates targeting syndecan-1 expressing cells and use thereof
GOLDMAKHER VIKTOR S5 citations71
APOPTOSIS TECHNOLOGY INC
3 patentsUS6605426B1Aug 12, 2003
Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
APOPTOSIS TECHNOLOGY INC11 citations71
US6902885B2Jun 7, 2005
Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
APOPTOSIS TECHNOLOGY INC1 citations60
US6218511B1Apr 17, 2001
Anti-apoptotic genes of human cytomegalovirus (HCMV) and their use
APOPTOSIS TECHNOLOGY INC5 citations56